# Questions for the focused review

The user requests improvements and an MD or chemical-reaction-dynamics pilot involving collagen and candidate crosslink molecules. Separate feasible numerical pilot controls from validated physical predictions. Ordinary fixed-topology classical MD does not model bond formation. A foundation MLIP fitted near equilibrium is not validated for a chemical reaction merely because it accepts changing atomic distances.

The completed Brev files are newer than the first critique's unconverged CPU pilot. Both list final_fmax near 0.02 eV/Angstrom, yet normalized stiffness estimates disagree strongly. Report the disagreement rather than averaging. The claim that dityrosine is stiffest in both outputs must be tested against all raw rows, including HLNL. Inspect how analyse() chooses five points near the global energy minimum: a minimum far from the initial anchor separation can reflect a different conformational basin.

For H5, source-audited prior checks across 62 saved rows found max beta*dY/dM = 0.2337099813 for beta=1.5, recovery rate 0.1251156624 to 0.1679235638 /h, and zero rows flagged bistable. Do not call these sampled conditions a proven near-bifurcation aging clock. Negative finite differences alone do not prove an unphysical derivative; estimate uncertainty and convergence.

For H8, distinguish a mapped reference-atom coordinate from the shortest intermolecular contact. The structures omit explicit stereochemistry and sample one conformer with one-axis rotations. The CPU and GPU comparisons also vary orientation count. Do not uniquely attribute their differences to either hardware or angular sampling. A decisive follow-up should separate chemistry, conformation, solvation, counterions, receptor sequence and proteoglycan core-protein contacts.

Output up to five high-value findings, plus one executable next-study design with controls and falsifiers. Make no clinical efficacy or validated reaction-rate claims. Additional software installation is subject to a separate written review and user approval.
